Small leucine-rich proteoglycans inhibit CNS regeneration by modifying the structural and mechanical properties of the lesion environment

• Published in: Nature communications Vol. 14; no. 1; pp. 6814 - 23
• Main Authors: Kolb, Julia, Tsata, Vasiliki, John, Nora, Kim, Kyoohyun, Möckel, Conrad, Rosso, Gonzalo, Kurbel, Veronika, Parmar, Asha, Sharma, Gargi, Karandasheva, Kristina, Abuhattum, Shada, Lyraki, Olga, Beck, Timon, Müller, Paul, Schlüßler, Raimund, Frischknecht, Renato, Wehner, Anja, Krombholz, Nicole, Steigenberger, Barbara, Beis, Dimitris, Takeoka, Aya, Blümcke, Ingmar, Möllmert, Stephanie, Singh, Kanwarpal, Guck, Jochen, Kobow, Katja, Wehner, Daniel
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 26.10.2023; Nature Publishing Group; Nature Portfolio
• Subjects: 13; 13/1; 13/106; 13/31; 13/51; 14; 14/19; 14/3; 14/32; 140/58; 631/378/1687/1825; 631/57; 631/80/304; Central nervous system; Danio rerio; Extracellular matrix; Humanities and Social Sciences; Lesions; Leucine; Mammals; Mechanical properties; Modulators; multidisciplinary; Nervous system; Proteoglycans; Recovery of function; Regeneration; Science; Science (multidisciplinary); Spinal cord; Viscoelasticity; Zebrafish
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-023-42339-7

Extracellular matrix (ECM) deposition after central nervous system (CNS) injury leads to inhibitory scarring in humans and other mammals, whereas it facilitates axon regeneration in the zebrafish. However, the molecular basis of these different fates is not understood. Here, we identify small leucine-rich proteoglycans (SLRPs) as a contributing factor to regeneration failure in mammals. We demonstrate that the SLRPs chondroadherin, fibromodulin, lumican, and prolargin are enriched in rodent and human but not zebrafish CNS lesions. Targeting SLRPs to the zebrafish injury ECM inhibits axon regeneration and functional recovery. Mechanistically, we find that SLRPs confer mechano-structural properties to the lesion environment that are adverse to axon growth. Our study reveals SLRPs as inhibitory ECM factors that impair axon regeneration by modifying tissue mechanics and structure, and identifies their enrichment as a feature of human brain and spinal cord lesions. These findings imply that SLRPs may be targets for therapeutic strategies to promote CNS regeneration. The mechanical properties of central nervous system (CNS) scar tissue are considered to contribute to axon regeneration failure. Here, the authors identify members of the small leucine-rich proteoglycan family as modulators of the inhibitory viscoelastic response of CNS lesions.